Avisi Technologies
Philadelphia, US · Delaware corporation · 4 known investors
Find your way into Avisi Technologies
Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma. Its products are investigational ophthalmic medical devices currently in clinical trials.
Founders & leadership
RJ
Rui Jing JianginFounder and CEO
PN
Paul NorrisinDirector
BK
Brandon KaoinFounder
GP
Gary PrudeninIndependent Director of the Board
Board
CM
Investors · 4
Funding
SEC filings, press & company announcements$16M disclosed across 2 of 5 rounds · 2022–2026
- $10.7MSeries AFeb 2026 · 2 sourcesSource ↗
▶$5.3MraisedNov 2022 · 19 investors · Other Health CareRule 506(b)
▶$5.3MraisedNov 2022 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rui Jing JiangExecutive Officer, Director
- Paul NorrisDirector
- Brandon KaoDirector
- Catherine MohrDirector
- Gary PrudenDirector
- Amount sold
- $5.3M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Avita Medical4 shared keywordsRECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.
Vuzix4 shared keywordsVuzix develops waveguide optics, display systems, and OEM platforms for device makers, and designs and manufactures enterprise AI smart glasses for warehouse, field service, healthcare, and industrial use. Its products and OEM programs serve defense, enterprise, consumer, and medical markets.
Companies competing with Avisi Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Avisi Technologies do?
- Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma. Its products are investigational ophthalmic medical devices currently in clinical trials.
- Who founded Avisi Technologies?
- Avisi Technologies was founded by Rui Jing Jiang.
- Who are Avisi Technologies's investors?
- Avisi Technologies's investors include MedVenture Partners, Inc., Golden Seeds, Good Growth Capital, Life Sciences Greenhouse Investments.
- How much funding has Avisi Technologies raised?
- Avisi Technologies has disclosed $16M raised across 2 of its 5 known rounds.
- Where is Avisi Technologies headquartered?
- Avisi Technologies is headquartered in Philadelphia, US.